Tag Archives: Bio Products Laboratory

May, 2018

February, 2017

  • 8 February

    BPL’s Gammaplex Wins FDA Approval for Treatment of PI and CITP

    ELSTREE, UK AND DURHAM, NC – FEBRUARY 7, 2017 – Bio Products Laboratory Limited (BPL), a leading manufacturer of plasma-derived protein therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved Gammaplex® 10% (immune globulin intravenous [human], 10% liquid) for the treatment of primary immunodeficiency (PI) and …

October, 2015